William Reed
Investor at Baseten
San Francisco Bay Area
Overview
Work Experience
General Partner
2015 - Current
Spark Capital is a venture capital firm that invests in the consumer, commerce, FinTech, software, frontier, and media sectors.
Series B Investor, Board Director
2023
Abridge is a medical conversation AI startup that structures and summarizes medical conversations for doctors and patients.
Raised $207,500,000.00 from Union Square Ventures, Redpoint, Bessemer Venture Partners, Mass General Brigham, Wittington Ventures, Spark Capital, IVP, Lightspeed Venture Partners, Kaiser Permanente Ventures and CVS Health Ventures.
Series C Investor, Board Director
2023
Headway is a mental healthcare system that helps users have access to affordable healthcare.
Raised $325,500,000.00 from Forerunner, Global Founders Capital, Spark Capital, Accel, Andreessen Horowitz and Thrive Capital.
Series C Investor
2019
Scale AI provides a data-oriented platform that assists in the development of AI applications.
Raised $2,602,620,000.00 from WCM Investment Management, Meta, Wellington Management, Y Combinator, Intel Capital, DFJ Growth, NVIDIA, Nat Friedman, Thrive Capital and Qualcomm Ventures.
Series C Investor
2016
Discord is an online voice, video, and text communication platform designed for creating communities.
Raised $995,408,718.00 from IPOSharks, Arcane Group and Flat Capital.
Series B Investor, Board Director
2023
Baseten is an AI infrastructure company that integrates machine learning into business operations, production, and processes.
Raised $60,000,000.00 from Charles Zedlewski, Greylock, basecase capital, IVP, Spark Capital, Lachy Groom and South Park Commons.
Series B, Series E Investor, Board Observer
2016
Handshake is a college career network that helps students and recent graduates find their next opportunity.
Raised $434,000,000.00 from Spark Capital, Chan Zuckerberg Initiative, Emerson Collective, Coatue, EQT Ventures, Valiant Peregrine Fund, True Ventures, Base10’s Advancement Initiative, Kleiner Perkins and Notable Capital.
Series D Investor
2020
Benchling is an IT company that provides a cloud-based software platform for biology researchers and research and development organizations.
Raised $411,900,000.00 from Lone Pine Capital, Franklin Templeton and Altimeter Capital.
Series B Investor
2018
Formation Bio is a drug development company that strives to provide treatments to patients faster by reimagining clinical trials.
Raised $528,000,000.00 from SV Angel, Andreessen Horowitz, Sanofi, FPV Ventures, Thrive Capital, Lachy Groom, Sequoia Capital and Emerson Collective.
Series C Investor, Board Director
2020